September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
Amazon: Oracle Partnership Highlights Margin Expansion Potential
Nvidia: Why You Should Buy Before It Hits $145
Apple: Enough To Turn The Odds In Its Favor – Still Buy
AMD Is Coming For Nvidia’s AI Lead
Nvidia: Goldman Sachs’ Hilarious Downside Case
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Ensysce Biosciences (ENSC) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 13, 2024 (10:56)
Sector: HealthcareThe share price of Ensysce Biosciences, Inc. (ENSC) now
Are you interested in Ensysce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ensysce Biosciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Ensysce Biosciences share be worth in 2024 - 2028?
When should I take profit in Ensysce Biosciences stock? When should I record a loss on Ensysce Biosciences stock? What are analysts' forecasts for Ensysce Biosciences stock? What is the future of Ensysce Biosciences stock? We forecast Ensysce Biosciences stock performance using neural networks based on historical data on Ensysce Biosciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Ensysce Biosciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Ensysce Biosciences shares. This happens once a day.
Historical and forecast chart of Ensysce Biosciences stock
The chart below shows the historical price of Ensysce Biosciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Ensysce Biosciences stock price can be found in the table below.
Long-term forecasts by years.
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm’s Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company is headquartered in La Jolla, CA.
Ensysce Biosciences daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 15 | 0.32 | 0.32 | 0.32 | 1.19 |
| Sep 16 | 0.32 | 0.32 | 0.32 | 1.09 |
| Sep 17 | 0.32 | 0.32 | 0.32 | 0.65 |
| Sep 18 | 0.31 | 0.31 | 0.32 | 0.66 |
| Sep 19 | 0.32 | 0.31 | 0.32 | 0.74 |
| Sep 20 | 0.32 | 0.31 | 0.32 | 1.36 |
| Sep 21 | 0.32 | 0.32 | 0.32 | 0.90 |
| Sep 22 | 0.32 | 0.32 | 0.32 | 1.08 |
| Sep 23 | 0.32 | 0.31 | 0.32 | 1.11 |
| Sep 24 | 0.31 | 0.31 | 0.32 | 0.93 |
| Sep 25 | 0.31 | 0.31 | 0.32 | 0.91 |
| Sep 26 | 0.31 | 0.31 | 0.32 | 0.90 |
| Sep 27 | 0.32 | 0.32 | 0.32 | 0.96 |
| Sep 28 | 0.32 | 0.32 | 0.32 | 0.80 |
| Sep 29 | 0.32 | 0.32 | 0.32 | 1.26 |
| Sep 30 | 0.32 | 0.32 | 0.32 | 1.05 |
| Oct 01 | 0.32 | 0.32 | 0.32 | 0.55 |
| Oct 02 | 0.32 | 0.32 | 0.32 | 0.74 |
| Oct 03 | 0.32 | 0.32 | 0.32 | 1.07 |
| Oct 04 | 0.32 | 0.32 | 0.32 | 1.03 |
| Oct 05 | 0.32 | 0.32 | 0.32 | 1.07 |
| Oct 06 | 0.32 | 0.32 | 0.32 | 0.87 |
| Oct 07 | 0.32 | 0.32 | 0.32 | 1.25 |
| Oct 08 | 0.32 | 0.32 | 0.32 | 0.71 |
| Oct 09 | 0.32 | 0.32 | 0.32 | 1.01 |
| Oct 10 | 0.33 | 0.32 | 0.33 | 0.95 |
| Oct 11 | 0.32 | 0.32 | 0.33 | 0.96 |
| Oct 12 | 0.32 | 0.32 | 0.33 | 1.34 |
| Oct 13 | 0.32 | 0.32 | 0.32 | 0.99 |
| Oct 14 | 0.32 | 0.32 | 0.32 | 1.25 |
Ensysce Biosciences Daily Price Targets
Ensysce Biosciences Stock Forecast 09-15-2024.
Forecast target price for 09-15-2024: $0.32.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 1.171%.
Pessimistic target level: 0.32
Optimistic target level: 0.32
Ensysce Biosciences Stock Forecast 09-16-2024.
Forecast target price for 09-16-2024: $0.32.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 1.074%.
Pessimistic target level: 0.32
Optimistic target level: 0.32
Ensysce Biosciences Stock Forecast 09-17-2024.
Forecast target price for 09-17-2024: $0.32.
Negative dynamics for Ensysce Biosciences shares will prevail with possible volatility of 0.648%.
Pessimistic target level: 0.32
Optimistic target level: 0.32
Ensysce Biosciences Stock Forecast 09-18-2024.
Forecast target price for 09-18-2024: $0.31.
Negative dynamics for Ensysce Biosciences shares will prevail with possible volatility of 0.658%.
Pessimistic target level: 0.31
Optimistic target level: 0.32
Ensysce Biosciences Stock Forecast 09-19-2024.
Forecast target price for 09-19-2024: $0.32.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 0.737%.
Pessimistic target level: 0.31
Optimistic target level: 0.32
Ensysce Biosciences Stock Forecast 09-20-2024.
Forecast target price for 09-20-2024: $0.32.
Positive dynamics for Ensysce Biosciences shares will prevail with possible volatility of 1.340%.
Pessimistic target level: 0.31
Optimistic target level: 0.32
ENSC (ENSC) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 0.33 | 0.33 | 0.33 | 2.22 |
| Nov. | 0.34 | 0.33 | 0.34 | 4.71 |
| Dec. | 0.34 | 0.34 | 0.35 | 5.27 |
Ensysce Biosciences forecast for this year
Ensysce Biosciences Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $0.32886. Pessimistic: $0.33. Optimistic: $0.33
Ensysce Biosciences Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.335602. Pessimistic: $0.33. Optimistic: $0.34
Ensysce Biosciences Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $0.343153. Pessimistic: $0.34. Optimistic: $0.35
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.35 | 0.34 | 0.36 | 4.72 |
| Feb | 0.34 | 0.33 | 0.35 | 6.37 |
| Mar | 0.35 | 0.34 | 0.36 | 4.18 |
| Apr | 0.37 | 0.35 | 0.38 | 6.20 |
| May | 0.37 | 0.36 | 0.38 | 5.22 |
| Jun | 0.37 | 0.37 | 0.39 | 5.25 |
| Jul | 0.36 | 0.36 | 0.37 | 2.90 |
| Aug | 0.36 | 0.36 | 0.37 | 4.49 |
| Sep | 0.37 | 0.35 | 0.38 | 6.79 |
| Oct | 0.36 | 0.35 | 0.38 | 5.93 |
| Nov | 0.37 | 0.35 | 0.38 | 6.05 |
| Dec | 0.38 | 0.37 | 0.40 | 5.78 |
Ensysce Biosciences (ENSC) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.39 | 0.37 | 0.40 | 6.45 |
| Feb | 0.38 | 0.36 | 0.39 | 6.80 |
| Mar | 0.39 | 0.38 | 0.40 | 5.25 |
| Apr | 0.39 | 0.38 | 0.40 | 4.54 |
| May | 0.38 | 0.37 | 0.39 | 6.10 |
| Jun | 0.38 | 0.38 | 0.39 | 4.36 |
| Jul | 0.39 | 0.38 | 0.40 | 6.50 |
| Aug | 0.38 | 0.37 | 0.39 | 5.81 |
| Sep | 0.39 | 0.38 | 0.40 | 4.68 |
| Oct | 0.38 | 0.37 | 0.38 | 4.48 |
| Nov | 0.40 | 0.39 | 0.41 | 4.35 |
| Dec | 0.39 | 0.38 | 0.40 | 5.35 |
Ensysce Biosciences information and performance
250 WEST 57TH ST., SUITE 2223, NEW YORK, NY, US
Market capitalization of the Ensysce Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ENSC shares in the company outstanding by the market price of one share.
EBITDA of Ensysce Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
